Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-08
2000-04-25
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530324, A61K 3800
Patent
active
060544295
ABSTRACT:
A improved method of treating pain is disclosed. The method includes administering to a subject an N-type voltage-sensitive calcium channel blocking omega conopeptide which is characterized by its ability to (a) inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind selectively to omega conopeptide MVIIA binding sites present in neuronal tissue. The method includes administering the omega conopeptide epidurally, preferably so that the compound is in prolonged or sustained contact with the epidural region.
REFERENCES:
patent: 5051403 (1991-09-01), Miljanich et al.
patent: 5163901 (1992-11-01), Eldor
patent: 5364842 (1994-11-01), Justice et al.
patent: 5451408 (1995-09-01), Mezei et al.
Bernards, C.M., "Effect of (Hydroxypropyl)-.beta.-cyclodextrin on Flux of Morphine, Fentanyl, Sufentanil, and Alfentanil Through the Spinal Meninges of Monkey," Journal of Pharmaceutical Sciences, 83(5):620-622 (1994).
Bernards, C.M. and Hill, H.F., "Physical and Chemical Properties of Drug Molecules Governing Their Diffusion Through the Spinal Meninges," Anesthesiology, 77(4):750-756 (1992).
Davar, G. et al., "MK-801 Blocks the Development of Thermal Hyperalgesia in a Rat Model of Experimental Painful Neuropathy," Brain Research, 553:327-330 (1991).
Dialog Information Services, File 351, WPIL Dialog Accession No. 010083868, WPI Accession No. 94-351581/44, Bristol-Myers Squibb Co: "Stabilised Injection Prepn--Comprises Deoxythymidine Nucleoisede and Stabiliser(s) Selected from Sugar Alcohol, Benzyl Alcohol, Phenol, etc"; & JP, A, 6247879, 940906, 9444 (Basic).
White, D.M., "Mechanism of Prostaglandin E.sub.2 -Induced Substance P Release from Cultured Sensory Neurons," Neuroscience, 70(2):561-565 (1996).
Xiao, W.-H. and Bennett, G.J., "Inhibition of Neuropathic Pain By N-type Calcium Channel Blockade with Omega-conopeptides Applied to the Site of Nerve Injury," Society for Neuroscience Abstracts, 20:559 (1994).
U.S. Patent Application No. 08/965,918 filed Nov. 7, 1997.
Malmberg et al. `Effect of Continuous Intrathecal Infusion of Conopeptides, N-type Calcium-Channel Blockers, on Behavior and Antinociception in the Formalin and Hot-plate Tests in Rats`, vol. 60, No. 1, pp. 83-90, 1995.
File DRUGU on STN No. 87-25878. Payne, R. `Role of Epidural and Intrathecal Narcotics and Peptides in teh Management of Cancer Pain`, Med. Clin. North Am. vol. 71, No. 2, pp. 313-327, 1987.
File Medline on STN No. 92081807. Littrell R A. `Epidural Analgesia`, vol. 48, No. 11, pp. 2460-2474, Nov. 1991.
Bernards et al. `Physical and Chemical Properties of Drug Molecules Governing their Diffuse Trhough the Spinal Meninges`, Anesthesiology, vol. 77, pp. 750-756, 1992.
Bernards et al. `Palmitoyl Carnitine Increases the Transmeningeal Flus of Hydrophilic but not Hydrophobic Compounds In Vitro`, Anesthesiology, vol. 84, No. 2, pp. 392-396, Feb. 1996.
Bowersox S. Scott
Gadbois Theresa
Luther Robert R.
Pettus Mark Raymond
Elan Pharmaceuticals Inc.
Gupta Anism
Mohr Judy M.
Stratford Carol A.
Tsang Cecilia J.
LandOfFree
Epidural method of producing analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epidural method of producing analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidural method of producing analgesia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-993373